Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: So the question is?

Based on the ALJ's decsion not to allow expenditures by PDS and Patriot to support the Domestic Industry requirement, coupled with the ALJ's decision to allow Garmin's arguments about the patent claims being changed with the 2009 re-exam to the extent that any expenditures prior to 2009 shouldn't be allowed .....does TPL have enough of an investment in asserting the patents since 2009 to satisfy the Domestic Industry requirement at this point?

I may be off the mark on this so please anyone with a more clear understanding, please comment.


Jun 07, 2013 06:58PM
1
Jun 07, 2013 07:38PM
Share
New Message
Please login to post a reply